Evaluating glycocalyx morphology and composition in frozen and formalin-fixed liver tumor sections.

Cancer Frozen sections Glycocalyx Lectin Liver metastasis Scanning electron microscopy

Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
15 Oct 2024
Historique:
received: 29 07 2024
revised: 14 10 2024
accepted: 14 10 2024
medline: 19 10 2024
pubmed: 19 10 2024
entrez: 18 10 2024
Statut: aheadofprint

Résumé

The glycocalyx (GCX) is a glycan structure on the vascular endothelium and cancer cells. It is crucial for blood flow regulation, tumor invasion, and cancer drug resistance. Understanding the role of GCX in human tumors could help develop new cancer biomarkers and therapies. This study aimed to demonstrate microstructural changes in human primary and metastatic liver tumors (henceforth termed liver tumors) by visualizing GCX using surgical specimens and comparing formalin-fixed paraffin-embedded sections (FFPEs) with frozen sections. The results of lectin staining were also compared between frozen and FFPE specimens to determine which was more useful for accurately assessing GCX structure and composition. Liver tumors and normal tissue samples from three patients were collected and processed into FFPEs and frozen sections, respectively. Lanthanum nitrate staining and scanning electron microscopy (SEM) were used to assess the GCX structures. Twenty lectins were analyzed for their glycan components in the samples. SEM revealed significant differences in GCX morphology among the cancer specimens. Frozen sections provided a more accurate GCX evaluation than FFPEs, showing distinct glycan compositions in hepatocellular carcinoma, colorectal carcinoma liver metastases, and melanoma liver metastases. Hepatocellular carcinoma samples exhibited a loss of N-acetylgalactosamine-related lectins. The results revealed that liver tumors have distinct and bulky GCX compared to normal liver tissue, while frozen sections are more reliable for GCX evaluation. These findings highlight glycan alterations in liver tumors and contribute to the development of new cancer therapies targeting GCX on tumor cell surfaces.

Sections du résumé

BACKGROUND BACKGROUND
The glycocalyx (GCX) is a glycan structure on the vascular endothelium and cancer cells. It is crucial for blood flow regulation, tumor invasion, and cancer drug resistance. Understanding the role of GCX in human tumors could help develop new cancer biomarkers and therapies.
AIM OBJECTIVE
This study aimed to demonstrate microstructural changes in human primary and metastatic liver tumors (henceforth termed liver tumors) by visualizing GCX using surgical specimens and comparing formalin-fixed paraffin-embedded sections (FFPEs) with frozen sections. The results of lectin staining were also compared between frozen and FFPE specimens to determine which was more useful for accurately assessing GCX structure and composition.
METHODS METHODS
Liver tumors and normal tissue samples from three patients were collected and processed into FFPEs and frozen sections, respectively. Lanthanum nitrate staining and scanning electron microscopy (SEM) were used to assess the GCX structures. Twenty lectins were analyzed for their glycan components in the samples.
RESULTS RESULTS
SEM revealed significant differences in GCX morphology among the cancer specimens. Frozen sections provided a more accurate GCX evaluation than FFPEs, showing distinct glycan compositions in hepatocellular carcinoma, colorectal carcinoma liver metastases, and melanoma liver metastases. Hepatocellular carcinoma samples exhibited a loss of N-acetylgalactosamine-related lectins.
CONCLUSION CONCLUSIONS
The results revealed that liver tumors have distinct and bulky GCX compared to normal liver tissue, while frozen sections are more reliable for GCX evaluation. These findings highlight glycan alterations in liver tumors and contribute to the development of new cancer therapies targeting GCX on tumor cell surfaces.

Identifiants

pubmed: 39423607
pii: S0344-0338(24)00571-5
doi: 10.1016/j.prp.2024.155660
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

155660

Informations de copyright

Copyright © 2024. Published by Elsevier GmbH.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Hiroyuki Tomita reports financial support was provided by JSPS KAKENHI, JST FOREST Program. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Masashi Kuno (M)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.

Hiroyuki Tomita (H)

Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan; Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, Japan. Electronic address: tomita.hiroyuki.y6@f.gifu-u.ac.jp.

Masahide Endo (M)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.

Kosuke Mori (K)

Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.

Akira Hara (A)

Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.

Takeshi Horaguchi (T)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Ryoma Yokoi (R)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Keita Matsumoto (K)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Hirokatsu Hayashi (H)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Masahiro Fukada (M)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Chika Takao (C)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Yuta Sato (Y)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Ryuichi Asai (R)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Itaru Yasufuku (I)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Jesse Yu Tajima (JY)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Shigeru Kiyama (S)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Yoshihiro Tanaka (Y)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan.

Nobuhisa Matsuhashi (N)

Department of Gastroenterological surgery, Gifu University School of Medicine, Gifu, Japan; Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, Japan. Electronic address: matsuhashi.nobuhisa.k6@f.gifu-u.ac.jp.

Classifications MeSH